Nutri Pharmaceuticals Research, Inc.
NRPR
$0.021
$0.005535.48%
| 12/31/2003 | |||||
|---|---|---|---|---|---|
| Net Income | -152.00K | ||||
| Total Depreciation and Amortization | 5.60K | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 101.60K | ||||
| Change in Net Operating Assets | 81.30K | ||||
| Cash from Operations | 36.50K | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -- | ||||
| Total Debt Issued | 300.00 | ||||
| Total Debt Repaid | -7.30K | ||||
| Issuance of Common Stock | 60.60K | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 53.60K | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 90.10K | ||||
